Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...

Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with a weakened ...

It has been discovered that a healthcare worker at Nepean Hospital's Birth Unit was infectious with hepatitis B between 2013 ...

The following is a summary of "Impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced ...

Chronic hepatitis B (CHB) remains a major global health challenge, with functional cure achieved in only a small subset of patients. Current oral antiviral agents effectively suppress viral ...

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

The American Gastroenterological Association (AGA) has released an updated clinical practice guideline on the prevention of ...

A study from National Taiwan University Hospital has unveiled how metabolic dysfunction significantly influences the ...

Hepatitis B virus (HBV) affects 300 million people worldwide and is a major driver of liver diseases. But while decades of research have led to vaccines, antivirals, and a better understanding of the ...

Plan B, also called the morning-after pill, is an emergency contraceptive pill taken after unprotected sex to prevent pregnancy. You don't, however, have to wait until the morning after sex to ...

The ELIMINATE-B trial is designed to investigate PBGENE-HBV at multiple ascending dose levels with three dose administrations per dose level in chronic Hepatitis B patients who are HBeAg-negative.

Additionally, non-invasive tests are not only valuable for assessing disease severity and guiding treatment decisions, but they also play a crucial role in monitoring disease progression or regression ...